The purpose of this research study is to understand how the monitoring of Patient-Reported Outcomes (PROs) could help improve surgical care for patients undergoing chest surgeries. PROs are symptoms directly reported by patients through the completion of a survey.
The goal of this study is to assess the feasibility of a nutrition program for individuals with cancer who are undergoing treatment. The nutrition program includes counseling from a registered dietitian, food logging, and nutrition symptom tracking.
Using online surveys to measure level of patient symptoms and seeing how regularly monitoring that impacts a patient's healthcare experience.
Develop a device to measure patient preferences in the treatment of bladder cancer.
The purpose of this study is to create a biobank by collecting and storing specimens, such as blood and tissue, along with medical information such as demographics and treatment, from a large group of patients with pancreatic tumors. This biobank can then be used by future studies focused on pancreatic tumors.
To compare the prevalence, severity, and timing of chronic health conditions (CHC) in a cohort of patients with DS-AL (Down Syndrome Acute Leukemia) with age-comparable DS individuals that have no cancer history. Our secondary objectives will compare NP (Neuro-Psychological) and health-related quality of life outcomes in survivors of DS-AL compared with age-comparable DS individuals with no cancer history, and will identify risk determinants of CHC and NP late effects among survivors of DS-AL.
For more information, please visit our website: https://cecs.unc.edu The purpose of this research study is to learn more about the diagnosis, treatment, and survivorship experiences of adults with endometrial cancer. Initial enrollment goals are for 1,800 adults living in North Carolina at the time of their recent first diagnosis of endometrial cancer. This project will provide important data for integrating tumor biology, access to care, and other factors to identify contributors, and potential areas for intervention to address endometrial cancer disparities. Study staff will pursue annual follow-ups with participants, requesting updates to treatment status and quality of life measures for approximately 5yrs.
We will identify changes in the numbers, seriousness, and outcomes of breast cancers diagnosed during the COVID-19 pandemic, compared to before the pandemic.
The purpose of this research study is to assess the patient-level, healthcare provider/system-level, and community-level barriers to resolving abnormal mammograms and initiation of treatment of breast cancer in the 3 geographic regions of North Carolina: the greater Charlotte area, the Northwest, and the Northeast. These areas include the following counties: Anson, Cabarrus, Cleveland, Gaston, Lincoln, Mecklenburg, Stanly, Union, Edgecombe, Halifax, Nash, Northampton, Wilson , Ashe, Alleghany, Surry, Stokes, Watauga, Wilkes, Yadkin, Forsyth, Avery, Caldwell, Alexander, Iredell, Davie, Davidson, Burke, Catawba, and Rowan. These barriers can include obtainment of biopsies and other diagnostic procedures for resolving abnormal mammograms abnormalities or breast symptoms, access to care providers after breast cancer diagnosis, and initiation of appropriate surgical, chemotherapy, and radiation treatments after diagnosis.
The CMR is a population based breast imaging registry for women screened for breast cancer in NC.